NTLA CIK: 1652130

Intellia Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.23
FY22:
−0.33
FY23:
−0.39
FY24:
−0.35
FY25:
−0.39
Change from FY21 to FY25
billions USD
FY21:
−0.55
FY22:
0.16
FY23:
−0.03
FY24:
0.13
FY25:
0.23
Change from FY21 to FY25
billions USD
FY21:
0.74
FY22:
0.58
FY23:
0.13
FY24:
0.19
FY25:
0.13
billions USD
FY21:
−0.04
FY22:
0.41
FY23:
−0.30
FY24:
−0.04
FY25:
−0.04
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.24
FY22:
−0.35
FY23:
−0.41
FY24:
−0.35
FY25:
−0.40

All amounts in billions USD Data source:SEC EDGAR